0000906304-12-000327.txt : 20120126
0000906304-12-000327.hdr.sgml : 20120126
20120126163501
ACCESSION NUMBER: 0000906304-12-000327
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20120126
DATE AS OF CHANGE: 20120126
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Syneron Medical Ltd.
CENTRAL INDEX KEY: 0001291361
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-80182
FILM NUMBER: 12548107
BUSINESS ADDRESS:
BUSINESS PHONE: 972-4-909-6200
MAIL ADDRESS:
STREET 1: INDUSTRIAL ZONE
STREET 2: P.O.B. 550
CITY: YOKNEAM ILLIT
STATE: L3
ZIP: 20692
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: ROYCE & ASSOCIATES LLC
CENTRAL INDEX KEY: 0000906304
IRS NUMBER: 522343049
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 745 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10151
BUSINESS PHONE: 212-508-4500
MAIL ADDRESS:
STREET 1: 745 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10151
FORMER COMPANY:
FORMER CONFORMED NAME: ROYCE & ASSOCIATES INC /NY
DATE OF NAME CHANGE: 19990329
FORMER COMPANY:
FORMER CONFORMED NAME: QUEST ADVISORY CORP/NY
DATE OF NAME CHANGE: 19970805
SC 13G/A
1
elos2.txt
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Information statement pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No.2)
Syneron Medical Ltd. (PFIC)
(Name of Issuer)
Common Stock
(Title of Class of Securities)
M87245102
(CUSIP Number)
Date of Event Which Requires Filing of this Statement: December 31, 2011
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. M87245102 13G
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Royce & Associates, LLC 52-2343049
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
NUMBER OF 5 SOLE VOTING POWER
SHARES 1,461,059
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 1,461,059
PERSON 8 SHARED DISPOSITIVE POWER
WITH
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON 1,461,059
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES [ ]
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.21%
12 TYPE OF REPORTING PERSON
IA
CUSIP No. M87245102 13G
Item 1(a) Name of Issuer:
Syneron Medical Ltd. (PFIC)
Item 1(b) Address of Issuer's Principal Executive Offices:
Office of the Secretary
Industrial Zone
Item 2(a) Name of Persons Filing:
Royce & Associates, LLC
Item 2(b) Address of Principal Business Office, or, if None, Residence:
745 Fifth Avenue, New York, NY 10151
Item 2(c) Citizenship:
New York Corporation
Item 2(d) Title of Class of Securities:
Common Stock
Item 2(e) CUSIP Number:
M87245102
Item 3 If this statement is filed pursuant to rules 13d-1(b), or 13d-
2(b), check whether the person filing is a:
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in Section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act
(d) [ ] Investment Company registered under Section 8 of
the Investment Company Act
(e) [X] Investment Adviser registered under Section 203 of
the Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee
Retirement Income Security Act of 1974 or Endowment Fund
(g) [ ] Parent Holding Company, in accordance with Rule 13d-1 (b)(ii)(G)
(h) [ ] Group
CUSIP No. M87245102 13G
Item 4 Ownership
(a) Amount Beneficially Owned:
1,461,059
(b) Percent of Class:
4.21%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
1,461,059
(ii) shared power to vote or to direct the vote
__________
(iii) sole power to dispose or to direct the disposition
of 1,461,059
(iv) shared power to dispose or to direct the
disposition of __________
Item 5 Ownership of Five Percent or Less of a Class. [ X ]
Item 6 Ownership of More than Five Percent on Behalf of Another Person .
NOT APPLICABLE
Item 7 Identification and Classification of the Subsidiary Which Acquired
The Security Being Reported on by the Parent Holding
Company.
NOT APPLICABLE
Item 8 Identification and Classification of Members of the Group.
NOT APPLICABLE
Item 9 Notice of Dissolution of Group.
NOT APPLICABLE
CUSIP No. M87245102 13G
Item 10 Certification.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the ordinary
course of business and were not acquired and are not held for the purpose of
or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with
or as a participant in any transaction having that purpose or effect.
Signature
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement with respect
to it is true, complete and correct.
Date: January 26, 2012
By: Daniel A. O'Byrne, Vice President